Cannabidiol. Cannabidiol (CBD) is one of at least 60 active cannabinoids identified in cannabis. It is a major constituent of the plant, accounting for up to 40% of the plant's extract, as a non-psychotropic phytocannabinoid. CBD is considered to have a wider scope of medical applications than tetrahydrocannabinol (THC). An orally-administered liquid containing CBD has received orphan drug status in the US, for use as a treatment for dravet syndrome under the brand name, Epidiolex. Clinical applications The bud of a Cannabis sativa flower coated with trichomes Antimicrobial actions CBD absorbed transcutaneously may attenuate the increased sebum production at the root of acne. Neurological effects A 2010 study found that strains of cannabis containing higher concentrations of cannabidiol did not produce short-term memory impairment vs. strains with similar concentrations of THC, but lower concentrations of CBD.
Parkinson's disease Psychotropic effect Cancer Cannabidiol CBD - GrowKind.com Marijuana Cultivation Forum. Here is a great bit of info iv posted that is from the cannibis growers bible by greg green which is freely available online.Peace Cannabinoids and the High The marijuana high is a complex experience.
It involves a wide range of psychical, physical, and emotional responses. The high is a subjective experience based in the individual - one's personality, mood, disposition, and experience with the drug. Given the person, the intensity of the high depends primarily on the amount of THC present in the marijuana. Grass having a THC concentration of three percent would be considered excellent quality by anyone's standards. Marijuana (plant material) is sometimes rated more potent that the content of delta-9 THC alone would suggest. This field is still in its infancy. Another possibility for higher potency is that homologues of delta-9 THC with longer side chains at C-3 (and higher activity) might be found in certain marijuana varieties.
Production of Cannabinoids by Cannabis 1. Type I Type II. THERAPEUTIC USES OF CANNABIDIOL COMPOUNDS - HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LlIMITED. This invention relates to the use of cannabidiol compounds in therapy. The following is a list of prior art which are considered to be pertinent for describing the state of the art in the field of the invention. Acknowledgement of these references herein will at times be made by indicating their number(s) from the list below next to specific passages herein. 1.
Varga, K., Lake, K., Martin, B. R. & Kunos, G. Cannabinoids are natural and synthetic compounds structurally or pharmacologically related to the constituents of the plant Cannabis sativa or to the endogenous agonists (endocannabinoids) of the cannabinoid receptors CB 1 or CB2 [Pertwee, R. In a rat model it was shown that anandamide has a physiological triphasic effect on the cardiovascular system consisting of initial reduction in heart rate and blood pressure, followed by a brief pressor response, and a third prominent phase of reduction in both blood pressure and heart rate1. Cannabidiol (CAS 13956-29-1) Antioxidant activity has been reported to be a general property of the phenolic components of marijuana. Unlike Δ9-THC, cannabidiol can be administered at relatively high doses without undesired toxic or psychological effects.1 Cannabidiol at a concentration of 10 µM was neuroprotective against both excitatory neurotransmitter (glutamate) and oxidant (hydroperoxide) induced neurotoxicity.2 1 Consroe, P., Laguna, J., Allender, J., et al.
Controlled clinical trial of cannabidiol in Huntington’s disease. Pharmacol Biochem Behav 40 701-708 (1991). 2 Hampson, A.J., Grimaldi, M., Axelrod, J., et al.